1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
IL-17 targeting biologics are redefining therapeutic strategies for immune-mediated diseases, with senior leaders closely monitoring advancements in precision medicine, regulatory landscapes, and commercial models.
Market Snapshot of the IL-17 Targeting Biologics Sector
The IL-17 biologics market is progressing at a strong CAGR, driven by increasing clinical acceptance, innovative therapies, and a robust regulatory pipeline. Key pharmaceutical companies are capitalizing on significant growth opportunities across North America, EMEA, and Asia-Pacific. Accelerated by approvals for new indications and evolving technology platforms, biologic agents targeting interleukin-17 have become pivotal in managing conditions previously reliant on broad-spectrum immunosuppressants. Strategic alliances and regionally nuanced commercialization approaches further reinforce sector momentum.
Scope & Segmentation of IL-17 Biologics Report
This report segments the IL-17 biologics market to provide targeted insights into commercial and clinical priorities:
- Indications: Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriatic Arthritis
- Mechanisms: IL-17A F Inhibitors, IL-17A Inhibitors, IL-17Ra Inhibitors
- Drug Classes: Monoclonal Antibody, Fusion Protein
- Routes of Administration: Intravenous, Subcutaneous (Auto Injector, Prefilled Syringe)
- End Users: Home Care Setting, Private/Public Hospitals, Specialty Centers
- Formulations: Auto Injector, Prefilled Syringe, Vial
- Distribution Channels: Distributor, Hospital Pharmacy, Online Pharmacy, Chain Pharmacy, Independent Pharmacy
- Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Key Companies: Novartis AG, Eli Lilly and Company, Amgen Inc., UCB S.A., PJSC BIOCAD, Affibody AB
Key Takeaways for Decision-Makers
- Selective IL-17 inhibition is influencing the transition from broad immune suppression to precision-based treatment in chronic inflammatory and autoimmune disorders.
- Next-generation molecules are designed to offer improved specificity, extended dosing intervals, and increased patient adherence.
- Integration of digital tools, including connected auto-injectors and adherence platforms, is enhancing patient support and real-world outcomes.
- Biosimilar entry and adaptive regulatory pathways are shaping market competition and stimulating investments in advanced manufacturing and cost-containment strategies.
- Collaborative care models and regional alliances are expanding access, supporting patient engagement, and optimizing long-term disease management strategies.
Tariff Impact: United States 2025 Policy Shift
Recent U.S. tariff measures have required manufacturers to renegotiate supply contracts and modify production plans. Increased oversight in logistics and compliance has driven adoption of advanced cold-chain and supply-chain tracking technologies. Manufacturers are responding by expanding local infrastructure and diversifying suppliers to minimize tariff exposure. Engagement with policymakers remains pivotal to maintain patient access and affordability amid evolving regulations.
Methodology & Data Sources
This market research integrates comprehensive secondary sources—peer-reviewed literature, regulatory filings, and patent databases—with in-depth interviews from industry stakeholders. Quantitative clinical trial analysis and triangulation of qualitative insights ensure robust, validated findings. Internal expert panels and real-time data checks safeguard methodological rigor and result accuracy.
Why This Report Matters
- Enables executive teams to benchmark technology adoption, market entry strategies, and supply chain evolution in the IL-17 targeting biologics domain.
- Equips commercial, clinical, and regulatory leaders with practical, evidence-based intelligence to support strategic planning and stakeholder communication.
Conclusion
The IL-17 targeting biologics market is defined by accelerated innovation, strategic partnerships, and adaptable commercialization approaches. Senior decision-makers can leverage these insights to inform next steps and maintain competitive advantage in an evolving landscape.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Real-world evidence studies demonstrating long-term safety and sustained efficacy of IL-17 inhibitors in diverse patient populations
5.2. Commercial launch of next-generation IL-17 inhibitors with extended dosing intervals and optimized subcutaneous delivery for improved patient adherence
5.3. Assessment of biosimilar entry strategies influencing pricing pressure and market share dynamics in the IL-17 biologic therapy segment
5.4. Expansion of IL-17 targeting biologics into emerging indications such as hidradenitis suppurativa and uveitis driven by robust clinical trial pipelines
5.5. Implementation of value-based contracting models between payers and manufacturers for IL-17 therapies to align treatment outcomes with reimbursement
5.2. Commercial launch of next-generation IL-17 inhibitors with extended dosing intervals and optimized subcutaneous delivery for improved patient adherence
5.3. Assessment of biosimilar entry strategies influencing pricing pressure and market share dynamics in the IL-17 biologic therapy segment
5.4. Expansion of IL-17 targeting biologics into emerging indications such as hidradenitis suppurativa and uveitis driven by robust clinical trial pipelines
5.5. Implementation of value-based contracting models between payers and manufacturers for IL-17 therapies to align treatment outcomes with reimbursement
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. IL-17 Targeting Biological Drugs Market, by Indication
8.1. Introduction
8.2. Ankylosing Spondylitis
8.3. Juvenile Idiopathic Arthritis
8.4. Plaque Psoriasis
8.5. Psoriatic Arthritis
8.2. Ankylosing Spondylitis
8.3. Juvenile Idiopathic Arthritis
8.4. Plaque Psoriasis
8.5. Psoriatic Arthritis
9. IL-17 Targeting Biological Drugs Market, by Mechanism
9.1. Introduction
9.2. Il-17A F Inhibitors
9.3. Il-17A Inhibitors
9.4. Il-17Ra Inhibitors
9.2. Il-17A F Inhibitors
9.3. Il-17A Inhibitors
9.4. Il-17Ra Inhibitors
10. IL-17 Targeting Biological Drugs Market, by Drug Class
10.1. Introduction
10.2. Fusion Protein
10.3. Monoclonal Antibody
10.2. Fusion Protein
10.3. Monoclonal Antibody
11. IL-17 Targeting Biological Drugs Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Subcutaneous
11.3.1. Auto Injector
11.3.2. Prefilled Syringe
11.2. Intravenous
11.3. Subcutaneous
11.3.1. Auto Injector
11.3.2. Prefilled Syringe
12. IL-17 Targeting Biological Drugs Market, by End User
12.1. Introduction
12.2. Home Care Setting
12.3. Hospital
12.3.1. Private Hospital
12.3.2. Public Hospital
12.4. Specialty Center
12.2. Home Care Setting
12.3. Hospital
12.3.1. Private Hospital
12.3.2. Public Hospital
12.4. Specialty Center
13. IL-17 Targeting Biological Drugs Market, by Formulation
13.1. Introduction
13.2. Auto Injector
13.3. Prefilled Syringe
13.4. Vial
13.2. Auto Injector
13.3. Prefilled Syringe
13.4. Vial
14. IL-17 Targeting Biological Drugs Market, by Distribution Channel
14.1. Introduction
14.2. Distributor
14.3. Hospital Pharmacy
14.4. Online Pharmacy
14.5. Retail Pharmacy
14.5.1. Chain Pharmacy
14.5.2. Independent Pharmacy
14.2. Distributor
14.3. Hospital Pharmacy
14.4. Online Pharmacy
14.5. Retail Pharmacy
14.5.1. Chain Pharmacy
14.5.2. Independent Pharmacy
15. Americas IL-17 Targeting Biological Drugs Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa IL-17 Targeting Biological Drugs Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific IL-17 Targeting Biological Drugs Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Novartis AG
18.3.2. Eli Lilly and Company
18.3.3. Amgen Inc.
18.3.4. UCB S.A.
18.3.5. PJSC BIOCAD
18.3.6. Affibody AB
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Novartis AG
18.3.2. Eli Lilly and Company
18.3.3. Amgen Inc.
18.3.4. UCB S.A.
18.3.5. PJSC BIOCAD
18.3.6. Affibody AB
List of Figures
FIGURE 1. IL-17 TARGETING BIOLOGICAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. IL-17 TARGETING BIOLOGICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. IL-17 TARGETING BIOLOGICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHAI
FIGURE 30. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 31. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHCONTACTS
FIGURE 32. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. IL-17 TARGETING BIOLOGICAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. IL-17 TARGETING BIOLOGICAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHAI
FIGURE 30. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 31. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHCONTACTS
FIGURE 32. IL-17 TARGETING BIOLOGICAL DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IL-17 TARGETING BIOLOGICAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY JUVENILE IDIOPATHIC ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY JUVENILE IDIOPATHIC ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A F INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A F INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17RA INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17RA INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 130. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 131. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 136. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 137. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 150. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 252. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 253. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 272. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 273. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY JUVENILE IDIOPATHIC ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY JUVENILE IDIOPATHIC ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A F INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A F INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17A INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17RA INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY IL-17RA INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SPECIALTY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 130. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 131. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 136. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 137. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. CANADA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 150. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 252. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 253. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 262. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 263. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. GERMANY IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 272. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 273. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 274. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 275. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 282. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 283. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. FRANCE IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY MECHANISM, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA IL-17 TARGETING BIOLOGICAL DRUGS MARKET SIZE, BY SUBCUTANEOUS, 2018-2024 (USD MILLION)
Samples
LOADING...
Companies Mentioned
The companies profiled in this IL-17 Targeting Biological Drugs Market report include:- Novartis AG
- Eli Lilly and Company
- Amgen Inc.
- UCB S.A.
- PJSC BIOCAD
- Affibody AB
